Female climacteric health-care food

Abstract

The invention discloses a female climacteric health-care food which is characterized by comprising substances in parts by weight as follows: 14-20 parts of mint, 5-8 parts of rhizoma polygonati, 2-8 parts of atractylodes macrocephala, 2-5 parts of white peony roots, 11-20 parts of ginseng extracts, 14-23 parts of ganoderma extracts, 9-14 parts of starch, 3-7 parts of potatoes, 5-8 parts of highland barley, 3-8 parts of broad beans, 3-9 parts of donkey-hide glue, 1-5 parts of ferula asafoetida, 2-6 parts of tangerine peel and 3-7 parts of fatty acid. The female climacteric health-care food has the benefits as follows: natural ingredients of various substances are scientifically extracted, a health care product easy to assimilate by middle and old aged women is prepared through reasonable combination, and effective active ingredients adjust the immunity of bodies and activate an estrogen secretion level in the bodies of the middle and old aged women, so that free radicals are scavenged, and functions of resisting oxidation, delaying senescence and relieving climacteric syndromes are realized.

Description

technical field [0001] The invention relates to a climacteric health food for women. Background technique [0002] Modern medicine believes that menopausal syndrome refers to a group of syndromes in which the function of the autonomic nervous system is mainly accompanied by neuropsychological symptoms due to the gradual decline of nest function and the decline of estrogen levels before and after menopause. It is also called perimenopausal syndrome. . With the significant extension of people's life expectancy, the average life course of women after menopause is greatly extended, seriously affecting the health problems and quality of life of perimenopause and postmenopause, which account for 1 / 3 of women's lifetime. [0003] Menopausal syndrome occurs along with the aging of the human body. During the aging process of the human body, various functions and material structures of the body are significantly changed, the most prominent of which is the obvious decline in the immun...

AI Technical Summary

Problems solved by technology

However, long-term hormone replacement therapy increases the risk of endometrial cancer

Although hormone replacement therapy combined with progesterone can reduce this risk, the risk of breast cancer and cardiovascular and cerebrovascular diseases increases. The adverse reactions caused by long-term clinical application of estrogen have always been the main reason for restricting its use.